Home Healthcare Biotechnology mRNA Therapeutics Market

mRNA Therapeutics Market Size, Share & Trends Analysis Report By Type (Prophylactic, Therapeutic), By Application (Oncology, Infectious Diseases, Rare Genetic Diseases, Others), By End User (Hospitals & Clinics, Research Organization, Others) and By Country (U.S., Canada) Forecasts, 2026-2034

Last Updated: July 10, 2026 | Author: Dhanashri B | Format: | Report Code: SR8045DR | Pages: 205
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. mRNA Therapeutics Market, By Type 2022-2034 (USD MILLION/ Units)
    1. Prophylactic
    2. Therapeutic
  2. mRNA Therapeutics Market, By Application 2022-2034 (USD MILLION/ Units)
    1. Oncology
    2. Infectious Diseases
    3. Rare Genetic Diseases
    4. Others
  3. mRNA Therapeutics Market, By End User 2022-2034 (USD MILLION/ Units)
    1. Hospitals & Clinics
    2. Research Organization
    3. Others
  4. Regional mRNA Therapeutics Market
    1. North America
      1. North America mRNA Therapeutics Market By Type 2022-2034 (USD MILLION/ Units)
        1. Prophylactic
        2. Therapeutic
      2. North America mRNA Therapeutics Market By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Rare Genetic Diseases
        4. Others
      3. North America mRNA Therapeutics Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Organization
        3. Others
      4. U.S. mRNA Therapeutics Market
        1. U.S. mRNA Therapeutics Market By Type 2022-2034 (USD MILLION/ Units)
          1. Prophylactic
          2. Therapeutic
        2. U.S. mRNA Therapeutics Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Infectious Diseases
          3. Rare Genetic Diseases
          4. Others
        3. U.S. mRNA Therapeutics Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals & Clinics
          2. Research Organization
          3. Others
      5. Canada mRNA Therapeutics Market
        1. Canada mRNA Therapeutics Market By Type 2022-2034 (USD MILLION/ Units)
          1. Prophylactic
          2. Therapeutic
        2. Canada mRNA Therapeutics Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Infectious Diseases
          3. Rare Genetic Diseases
          4. Others
        3. Canada mRNA Therapeutics Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals & Clinics
          2. Research Organization
          3. Others
    2. Europe
      1. Europe mRNA Therapeutics Market By Type 2022-2034 (USD MILLION/ Units)
        1. Prophylactic
        2. Therapeutic
      2. Europe mRNA Therapeutics Market By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Rare Genetic Diseases
        4. Others
      3. Europe mRNA Therapeutics Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Organization
        3. Others
      4. U.K. mRNA Therapeutics Market
        1. U.K. mRNA Therapeutics Market By Type 2022-2034 (USD MILLION/ Units)
          1. Prophylactic
          2. Therapeutic
        2. U.K. mRNA Therapeutics Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Infectious Diseases
          3. Rare Genetic Diseases
          4. Others
        3. U.K. mRNA Therapeutics Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals & Clinics
          2. Research Organization
          3. Others
      5. Germany mRNA Therapeutics Market
        1. Germany mRNA Therapeutics Market By Type 2022-2034 (USD MILLION/ Units)
          1. Prophylactic
          2. Therapeutic
        2. Germany mRNA Therapeutics Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Infectious Diseases
          3. Rare Genetic Diseases
          4. Others
        3. Germany mRNA Therapeutics Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals & Clinics
          2. Research Organization
          3. Others
      6. France mRNA Therapeutics Market
        1. France mRNA Therapeutics Market By Type 2022-2034 (USD MILLION/ Units)
          1. Prophylactic
          2. Therapeutic
        2. France mRNA Therapeutics Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Infectious Diseases
          3. Rare Genetic Diseases
          4. Others
        3. France mRNA Therapeutics Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals & Clinics
          2. Research Organization
          3. Others
      7. Spain mRNA Therapeutics Market
        1. Spain mRNA Therapeutics Market By Type 2022-2034 (USD MILLION/ Units)
          1. Prophylactic
          2. Therapeutic
        2. Spain mRNA Therapeutics Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Infectious Diseases
          3. Rare Genetic Diseases
          4. Others
        3. Spain mRNA Therapeutics Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals & Clinics
          2. Research Organization
          3. Others
      8. Italy mRNA Therapeutics Market
        1. Italy mRNA Therapeutics Market By Type 2022-2034 (USD MILLION/ Units)
          1. Prophylactic
          2. Therapeutic
        2. Italy mRNA Therapeutics Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Infectious Diseases
          3. Rare Genetic Diseases
          4. Others
        3. Italy mRNA Therapeutics Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals & Clinics
          2. Research Organization
          3. Others
      9. Russia mRNA Therapeutics Market
        1. Russia mRNA Therapeutics Market By Type 2022-2034 (USD MILLION/ Units)
          1. Prophylactic
          2. Therapeutic
        2. Russia mRNA Therapeutics Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Infectious Diseases
          3. Rare Genetic Diseases
          4. Others
        3. Russia mRNA Therapeutics Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals & Clinics
          2. Research Organization
          3. Others
      10. Nordic mRNA Therapeutics Market
        1. Nordic mRNA Therapeutics Market By Type 2022-2034 (USD MILLION/ Units)
          1. Prophylactic
          2. Therapeutic
        2. Nordic mRNA Therapeutics Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Infectious Diseases
          3. Rare Genetic Diseases
          4. Others
        3. Nordic mRNA Therapeutics Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals & Clinics
          2. Research Organization
          3. Others
      11. Benelux mRNA Therapeutics Market
        1. Benelux mRNA Therapeutics Market By Type 2022-2034 (USD MILLION/ Units)
          1. Prophylactic
          2. Therapeutic
        2. Benelux mRNA Therapeutics Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Infectious Diseases
          3. Rare Genetic Diseases
          4. Others
        3. Benelux mRNA Therapeutics Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals & Clinics
          2. Research Organization
          3. Others
      12. Rest of Europe mRNA Therapeutics Market
        1. Rest of Europe mRNA Therapeutics Market By Type 2022-2034 (USD MILLION/ Units)
          1. Prophylactic
          2. Therapeutic
        2. Rest of Europe mRNA Therapeutics Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Infectious Diseases
          3. Rare Genetic Diseases
          4. Others
        3. Rest of Europe mRNA Therapeutics Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals & Clinics
          2. Research Organization
          3. Others
    3. APAC
      1. APAC mRNA Therapeutics Market By Type 2022-2034 (USD MILLION/ Units)
        1. Prophylactic
        2. Therapeutic
      2. APAC mRNA Therapeutics Market By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Rare Genetic Diseases
        4. Others
      3. APAC mRNA Therapeutics Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Organization
        3. Others
      4. China mRNA Therapeutics Market
        1. China mRNA Therapeutics Market By Type 2022-2034 (USD MILLION/ Units)
          1. Prophylactic
          2. Therapeutic
        2. China mRNA Therapeutics Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Infectious Diseases
          3. Rare Genetic Diseases
          4. Others
        3. China mRNA Therapeutics Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals & Clinics
          2. Research Organization
          3. Others
      5. Korea mRNA Therapeutics Market
        1. Korea mRNA Therapeutics Market By Type 2022-2034 (USD MILLION/ Units)
          1. Prophylactic
          2. Therapeutic
        2. Korea mRNA Therapeutics Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Infectious Diseases
          3. Rare Genetic Diseases
          4. Others
        3. Korea mRNA Therapeutics Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals & Clinics
          2. Research Organization
          3. Others
      6. Japan mRNA Therapeutics Market
        1. Japan mRNA Therapeutics Market By Type 2022-2034 (USD MILLION/ Units)
          1. Prophylactic
          2. Therapeutic
        2. Japan mRNA Therapeutics Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Infectious Diseases
          3. Rare Genetic Diseases
          4. Others
        3. Japan mRNA Therapeutics Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals & Clinics
          2. Research Organization
          3. Others
      7. India mRNA Therapeutics Market
        1. India mRNA Therapeutics Market By Type 2022-2034 (USD MILLION/ Units)
          1. Prophylactic
          2. Therapeutic
        2. India mRNA Therapeutics Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Infectious Diseases
          3. Rare Genetic Diseases
          4. Others
        3. India mRNA Therapeutics Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals & Clinics
          2. Research Organization
          3. Others
      8. Australia mRNA Therapeutics Market
        1. Australia mRNA Therapeutics Market By Type 2022-2034 (USD MILLION/ Units)
          1. Prophylactic
          2. Therapeutic
        2. Australia mRNA Therapeutics Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Infectious Diseases
          3. Rare Genetic Diseases
          4. Others
        3. Australia mRNA Therapeutics Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals & Clinics
          2. Research Organization
          3. Others
      9. Taiwan mRNA Therapeutics Market
        1. Taiwan mRNA Therapeutics Market By Type 2022-2034 (USD MILLION/ Units)
          1. Prophylactic
          2. Therapeutic
        2. Taiwan mRNA Therapeutics Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Infectious Diseases
          3. Rare Genetic Diseases
          4. Others
        3. Taiwan mRNA Therapeutics Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals & Clinics
          2. Research Organization
          3. Others
      10. South East Asia mRNA Therapeutics Market
        1. South East Asia mRNA Therapeutics Market By Type 2022-2034 (USD MILLION/ Units)
          1. Prophylactic
          2. Therapeutic
        2. South East Asia mRNA Therapeutics Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Infectious Diseases
          3. Rare Genetic Diseases
          4. Others
        3. South East Asia mRNA Therapeutics Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals & Clinics
          2. Research Organization
          3. Others
      11. Rest of Asia-Pacific mRNA Therapeutics Market
        1. Rest of Asia-Pacific mRNA Therapeutics Market By Type 2022-2034 (USD MILLION/ Units)
          1. Prophylactic
          2. Therapeutic
        2. Rest of Asia-Pacific mRNA Therapeutics Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Infectious Diseases
          3. Rare Genetic Diseases
          4. Others
        3. Rest of Asia-Pacific mRNA Therapeutics Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals & Clinics
          2. Research Organization
          3. Others
    4. Middle East and Africa
      1. Middle East and Africa mRNA Therapeutics Market By Type 2022-2034 (USD MILLION/ Units)
        1. Prophylactic
        2. Therapeutic
      2. Middle East and Africa mRNA Therapeutics Market By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Rare Genetic Diseases
        4. Others
      3. Middle East and Africa mRNA Therapeutics Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Organization
        3. Others
      4. UAE mRNA Therapeutics Market
        1. UAE mRNA Therapeutics Market By Type 2022-2034 (USD MILLION/ Units)
          1. Prophylactic
          2. Therapeutic
        2. UAE mRNA Therapeutics Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Infectious Diseases
          3. Rare Genetic Diseases
          4. Others
        3. UAE mRNA Therapeutics Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals & Clinics
          2. Research Organization
          3. Others
      5. Turkey mRNA Therapeutics Market
        1. Turkey mRNA Therapeutics Market By Type 2022-2034 (USD MILLION/ Units)
          1. Prophylactic
          2. Therapeutic
        2. Turkey mRNA Therapeutics Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Infectious Diseases
          3. Rare Genetic Diseases
          4. Others
        3. Turkey mRNA Therapeutics Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals & Clinics
          2. Research Organization
          3. Others
      6. Saudi Arabia mRNA Therapeutics Market
        1. Saudi Arabia mRNA Therapeutics Market By Type 2022-2034 (USD MILLION/ Units)
          1. Prophylactic
          2. Therapeutic
        2. Saudi Arabia mRNA Therapeutics Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Infectious Diseases
          3. Rare Genetic Diseases
          4. Others
        3. Saudi Arabia mRNA Therapeutics Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals & Clinics
          2. Research Organization
          3. Others
      7. South Africa mRNA Therapeutics Market
        1. South Africa mRNA Therapeutics Market By Type 2022-2034 (USD MILLION/ Units)
          1. Prophylactic
          2. Therapeutic
        2. South Africa mRNA Therapeutics Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Infectious Diseases
          3. Rare Genetic Diseases
          4. Others
        3. South Africa mRNA Therapeutics Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals & Clinics
          2. Research Organization
          3. Others
      8. Egypt mRNA Therapeutics Market
        1. Egypt mRNA Therapeutics Market By Type 2022-2034 (USD MILLION/ Units)
          1. Prophylactic
          2. Therapeutic
        2. Egypt mRNA Therapeutics Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Infectious Diseases
          3. Rare Genetic Diseases
          4. Others
        3. Egypt mRNA Therapeutics Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals & Clinics
          2. Research Organization
          3. Others
      9. Nigeria mRNA Therapeutics Market
        1. Nigeria mRNA Therapeutics Market By Type 2022-2034 (USD MILLION/ Units)
          1. Prophylactic
          2. Therapeutic
        2. Nigeria mRNA Therapeutics Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Infectious Diseases
          3. Rare Genetic Diseases
          4. Others
        3. Nigeria mRNA Therapeutics Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals & Clinics
          2. Research Organization
          3. Others
      10. Rest of MEA mRNA Therapeutics Market
        1. Rest of MEA mRNA Therapeutics Market By Type 2022-2034 (USD MILLION/ Units)
          1. Prophylactic
          2. Therapeutic
        2. Rest of MEA mRNA Therapeutics Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Infectious Diseases
          3. Rare Genetic Diseases
          4. Others
        3. Rest of MEA mRNA Therapeutics Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals & Clinics
          2. Research Organization
          3. Others
    5. LATAM
      1. LATAM mRNA Therapeutics Market By Type 2022-2034 (USD MILLION/ Units)
        1. Prophylactic
        2. Therapeutic
      2. LATAM mRNA Therapeutics Market By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Rare Genetic Diseases
        4. Others
      3. LATAM mRNA Therapeutics Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Organization
        3. Others
      4. Brazil mRNA Therapeutics Market
        1. Brazil mRNA Therapeutics Market By Type 2022-2034 (USD MILLION/ Units)
          1. Prophylactic
          2. Therapeutic
        2. Brazil mRNA Therapeutics Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Infectious Diseases
          3. Rare Genetic Diseases
          4. Others
        3. Brazil mRNA Therapeutics Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals & Clinics
          2. Research Organization
          3. Others
      5. Mexico mRNA Therapeutics Market
        1. Mexico mRNA Therapeutics Market By Type 2022-2034 (USD MILLION/ Units)
          1. Prophylactic
          2. Therapeutic
        2. Mexico mRNA Therapeutics Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Infectious Diseases
          3. Rare Genetic Diseases
          4. Others
        3. Mexico mRNA Therapeutics Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals & Clinics
          2. Research Organization
          3. Others
      6. Argentina mRNA Therapeutics Market
        1. Argentina mRNA Therapeutics Market By Type 2022-2034 (USD MILLION/ Units)
          1. Prophylactic
          2. Therapeutic
        2. Argentina mRNA Therapeutics Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Infectious Diseases
          3. Rare Genetic Diseases
          4. Others
        3. Argentina mRNA Therapeutics Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals & Clinics
          2. Research Organization
          3. Others
      7. Chile mRNA Therapeutics Market
        1. Chile mRNA Therapeutics Market By Type 2022-2034 (USD MILLION/ Units)
          1. Prophylactic
          2. Therapeutic
        2. Chile mRNA Therapeutics Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Infectious Diseases
          3. Rare Genetic Diseases
          4. Others
        3. Chile mRNA Therapeutics Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals & Clinics
          2. Research Organization
          3. Others
      8. Colombia mRNA Therapeutics Market
        1. Colombia mRNA Therapeutics Market By Type 2022-2034 (USD MILLION/ Units)
          1. Prophylactic
          2. Therapeutic
        2. Colombia mRNA Therapeutics Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Infectious Diseases
          3. Rare Genetic Diseases
          4. Others
        3. Colombia mRNA Therapeutics Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals & Clinics
          2. Research Organization
          3. Others
      9. Rest of LATAM mRNA Therapeutics Market
        1. Rest of LATAM mRNA Therapeutics Market By Type 2022-2034 (USD MILLION/ Units)
          1. Prophylactic
          2. Therapeutic
        2. Rest of LATAM mRNA Therapeutics Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Infectious Diseases
          3. Rare Genetic Diseases
          4. Others
        3. Rest of LATAM mRNA Therapeutics Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals & Clinics
          2. Research Organization
          3. Others
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.